Department of Cardiology, IGMC, Shimla, 171001, H.P. India.
Department of Cardiology, IGMC, Shimla, 171001, H.P. India.
Indian Heart J. 2023 May-Jun;75(3):190-196. doi: 10.1016/j.ihj.2023.03.007. Epub 2023 Mar 30.
The data on clinical characteristics, treatment practices and out comes in patients with Non- ischemic Systolic Heart Failure (NISHF) is limited. We report clinical characteristics, treatment and outcomes in patients with NISHF.
1004 patients with NISHF were prospectively enrolled and their demographics, clinical characteristics, and treatment were recorded systematically. Patients were followed annually for a median of 3 years (1 year to 8 years) for allcause death, major adverse cardiovascular events (MACE); composite of all-cause death, hospitalization of heart failure, and or for stroke.
Patients of NISHF were middle-aged (58.8±16.2 years) population with severely depressed left ventricular ejection fraction (29.3±7.02%) and 31.1% had symptoms of advanced Heart failure. Hypertension (43.6%), obesity and or overweight (28.0%), Diabetes (15.0%), and valvular heart disease (11.8%) were the common risk factors. The guideline directed medical treatment was prescribed in more than 80% of the study cohort. Incidence of all cause death and MACE was 7 (6.8, 8.8) per 100 person years and 11(10, 13) per 100 person years respectively. The cumulative incidence of deaths and MACE was 35% (30%, 40%) and 49% (44%, 53%) at 8 years of follow-up.
Patients of NISHF were middle-aged population with severely depressed LV systolic function with significant incident morbidity and mortality. Early detection of risk factors and their risk management and enhancing the use of guideline directed treatment may improve the outcomes.
非缺血性收缩性心力衰竭(NISHF)患者的临床特征、治疗方法和结局的数据有限。我们报告了 NISHF 患者的临床特征、治疗方法和结局。
前瞻性纳入 1004 例 NISHF 患者,系统记录其人口统计学、临床特征和治疗情况。中位随访 3 年(1 年至 8 年),每年随访一次,以评估全因死亡、主要心血管不良事件(MACE);全因死亡、心力衰竭住院和/或中风的复合终点。
NISHF 患者为中老年人群(58.8±16.2 岁),左心室射血分数严重降低(29.3±7.02%),31.1%的患者有晚期心力衰竭症状。常见的危险因素包括高血压(43.6%)、肥胖或超重(28.0%)、糖尿病(15.0%)和瓣膜性心脏病(11.8%)。超过 80%的研究队列接受了指南指导的药物治疗。全因死亡和 MACE 的发生率分别为每 100 人年 7(6.8,8.8)例和每 100 人年 11(10,13)例。8 年随访时,死亡和 MACE 的累积发生率分别为 35%(30%,40%)和 49%(44%,53%)。
NISHF 患者为中老年人群,左心室收缩功能严重降低,发病率和死亡率较高。早期发现危险因素及其风险管理,并加强指南指导的治疗应用,可能改善结局。